This announcement is a separate document:
民生证券股份有限公司关于成都圣诺生物科技股份有限公司2024年半年度持续督导跟踪报告
Minsheng Securities Co., Ltd.'s continuous supervision and follow-up report on the Chengdu Shengnuo Biotechnology Co., Ltd.'s 2024 semi-annual report.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.